KR100686561B1 - Corynebacterium ammoniagenes cjxcv19 kccm-10692p having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant - Google Patents

Corynebacterium ammoniagenes cjxcv19 kccm-10692p having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant Download PDF

Info

Publication number
KR100686561B1
KR100686561B1 KR1020050113712A KR20050113712A KR100686561B1 KR 100686561 B1 KR100686561 B1 KR 100686561B1 KR 1020050113712 A KR1020050113712 A KR 1020050113712A KR 20050113712 A KR20050113712 A KR 20050113712A KR 100686561 B1 KR100686561 B1 KR 100686561B1
Authority
KR
South Korea
Prior art keywords
kccm
gmp
mutant
corynebacterium ammoniagenes
guanine
Prior art date
Application number
KR1020050113712A
Other languages
Korean (ko)
Inventor
박영훈
김현수
한종권
백민지
오기훈
심재익
홍국기
강태선
Original Assignee
씨제이 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 씨제이 주식회사 filed Critical 씨제이 주식회사
Priority to KR1020050113712A priority Critical patent/KR100686561B1/en
Application granted granted Critical
Publication of KR100686561B1 publication Critical patent/KR100686561B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/32Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A microorganism Corynebacterium ammoniagenes CJXCV19(KCCM-10692P) having low activity of degradation of guanine 5'-monophosphate(GMP) and a high-throughput screening method of the same microorganism are provided to reduce screening time, and produce guanine 5'-monophosphate(GMP) with higher yield from XMP(5'-xanthylic acid). The high-throughput screening method of a mutant of Corynebacterium ammoniagenes CJFXT0301(KCCM-10530) comprises the steps of: culturing the mutants of Corynebacterium ammoniagenes CJFXT0301(KCCM-10530) in a mini-well; inducing conversion reaction of the cultured mutants of Corynebacterium ammoniagenes CJFXT0301(KCCM-10530) mutant into guanine monophosphate(GMP); measuring the concentration of guanine monophosphate(GMP) in the conversion reaction and selecting the mutant showing absorbance of 0.8 at 290 nm when a parent strain shows absorbance of 0.8 or more at 290 nm, wherein the mutant of Corynebacterium ammoniagenes CJFXT0301(KCCM-10530) is Corynebacterium ammoniagenes CJXCV19(KCCM-10692P) which produces XMP(5'-xanthylic acid) and converts it into guanine 5'-monophosphate(GMP) with higher conversion rate.

Description

GMP 저분해 활성을 갖는 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P 및 변이주의 고속선별방법{Corynebacterium ammoniagenes CJXCV19 KCCM-10692P having low activity of degradation of guanine 5’- monophosphate and high-throughput screening method for mutant}Corynebacterium ammoniagenes CJXCV19 KCCM-10692P having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant}

도 1은 코리네박테리움 암모니아게네스 야생주의 소규모(mini-scale) 배양을 한 후 멀티 웰 리더를 이용하여 흡광도 526nm에서 세포농도를 측정한 결과를 나타내는 도이며,1 is a diagram showing the results of measuring the cell concentration at the absorbance of 526nm using a multi-well reader after mini-scale culture of Corynebacterium ammonia genes wild wine,

도 2는 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530 균주의 소규모 배양을 한 후 멀티 웰 리더를 이용하여 흡광도 526nm에서 세포농도를 측정한 결과를 나타내는 도이며,Figure 2 is a diagram showing the results of measuring the cell concentration at the absorbance of 526nm using a multi-well reader after small-scale culture of Corynebacterium ammonia genes CJXFT0301 KCCM-10530 strain,

도 3은 소규모에서의 5’-구아닐산(GMP) 분해 또는 전환 반응 결과를 나타내는 도이다.3 is a diagram showing the results of 5'-guanylic acid (GMP) degradation or conversion reaction in a small scale.

본 발명은 미생물에 돌연변이를 유발한 변이주들 중에서 GMP 저분해 또는 저전환 활성을 갖는 변이주의 고속선별방법, 상기 방법에 의해 선별된 변이주 코리네 박테리움 암모니아게네스 CJXCV19 KCCM-10692P 및 이를 이용한 GMP 생산방법에 관한 것이다.The present invention is a high-speed screening method of mutant strains having GMP low degradation or low conversion activity among the mutants causing mutations in microorganisms, mutant strain Corynebacterium ammonia genes selected by the method CJXCV19 KCCM-10692P and GMP production using the same It is about a method.

5’-구아닐산(GMP)은 5’-이노신산(inosine 5’-monophosphate: IMP)와 더불어 식품 조미 첨가제로 널리 이용되고 있는 물질이다. 5’-구아닐산은 그 자체로 버섯 맛을 내는 것으로 알려져 있으나, 주로 모노소디움 글루탐산(monosodium-glutamine acid: MSG)의 풍미를 강화하는 것으로 알려져 있다. 이러한 성질은 특히 5’-이노신산(IMP)과 같이 쓰여졌을 때 강하게 나타난다.5'-Guanylic Acid (GMP), along with 5'-Inosine acid (inosine 5'-monophosphate, IMP), is widely used as a food seasoning additive. 5'-Guanylic acid is known to taste mushrooms by itself, but is primarily known to enhance the flavor of monosodium-glutamine acid (MSG). This property is particularly strong when used with 5'-inosinic acid (IMP).

지금까지 알려진 5’-구아닐산의 제조방법은 첫째, 효모세포로부터 추출한 리보핵산(RNA)를 효소학적으로 분해하는 방법, 둘째, 미생물 발효법으로 5’-구아닐산(GMP)을 직접 발효하는 방법, 셋째, 미생물 발효법으로 생산한 구아노신을 화학적으로 인산화 시키는 방법, 넷째, 미생물 발효법으로 생산한 구아노신을 효소적 방법으로 인산화 시키는 방법, 다섯째, 미생물 발효법으로 생산한 5’-크산틸산(XMP)를 코리네형 미생물을 이용하여 5’-구아닐산으로 전환하는 방법, 여섯째, 미생물 발효법으로 생산한 5’-크산틸산(XMP)를 대장균을 이용하여 5’-구아닐산으로 전환시키는 방법을 들 수 있다. 상기의 방법들 중에서 첫번째 방법은 원료 수급 및 경제성에 문제가 있으며, 두번째 방법은 5’-구아닐산(GMP)의 세포막 투과성의 문제로 인하여 수율이 낮다는 단점이 있어 그 외의 방법이 공업적으로 주로 이용되고 있다. 특히, 여섯번째 방법인 5’-크산틸산(XMP)를 효소적으로 전환시키는 방법이 널리 이용되고 있다.Known methods for producing 5'-guanylic acid are firstly a method of enzymatically degrading ribonucleic acid (RNA) extracted from yeast cells, and secondly, a method of directly fermenting 5'-guanylic acid (GMP) by microbial fermentation. Chemical phosphorylation of guanosine produced by microbial fermentation method; fourth, phosphorylation of guanosine produced by microbial fermentation method; and fifth, 5'-xanthyl acid (XMP) produced by microbial fermentation method The method of converting to 5'-guanylic acid using the 6th method and the method of converting 5'-xanthyl acid (XMP) produced by the microbial fermentation method to 5'-guanylic acid using E. coli are mentioned. Among the above methods, the first method has a problem in supply and economics of raw materials, and the second method has a disadvantage in that the yield is low due to the problem of 5'-guanylic acid (GMP) cell membrane permeability. It is becoming. In particular, a sixth method, 5'-xanthyl acid (XMP), has been widely used.

코리네박테리움 암모니아게네스를 이용하여 5’-크산틸산(XMP)을 생산하고 대장균의 XMP aminase를 첨가하여 5’-구아닐산(GMP)으로 전환하는 방법은 5’-크산틸산(XMP)을 아미노화하여 GMP를 생성하는 한단계 반응이지만 동시에 ATP를 소모하여 AMP와 피로인산(PPi)을 생성하는 에너지 요구반응이다. 코리네박테리움 암모니아게네스는 포도당을 이용하여 ATP를 합성하는 활성을 가지고 있으므로 적당한 전환 반응 조건을 설정함으로써 ATP합성과 XMP 아미나아제(XMP aminase)반응을 동시에 일어나도록 한다. 균체 자체를 효소원으로 사용하는 방법은 다수의 효소군을 공급할 수 있다는 장점이 있으나 동시에 바람직하지 않은 부 반응이 일어난다는 단점을 갖고 있다. 5'-Xanthyl acid (XMP) is produced using Corynebacterium ammonia genes and 5'-xanthyl acid (XMP) is converted to 5'-guanylic acid (GMP) by adding XMP aminase from E. coli. It is a one-step reaction to produce GMP by aging, but at the same time, it consumes ATP to produce AMP and pyrophosphate (PPi). Corynebacterium ammonia genes have the activity of synthesizing ATP using glucose, so by setting appropriate conversion reaction conditions, ATP synthesis and XMP aminase reaction occur simultaneously. The method using the cells themselves as an enzyme source has the advantage of supplying a large number of enzyme groups, but at the same time has the disadvantage that undesirable side reactions occur.

5’-구아닐산(GMP)으로의 전환반응에서 문제가 되는 부 반응에는 생성물의 분해 또는 다른 물질로의 전환이 있다. 반응의 전환율을 높이기 위해서는 ATP 재생을 유지하면서 만들어지는 5’-구아닐산(GMP)의 분해 또는 전환이 약하게 일어나거나 일어나지 않는 균주를 개발하는 것이 필요하다.Side reactions that are problematic in the conversion to 5′-guanylic acid (GMP) include degradation of the product or conversion to other substances. In order to increase the conversion of the reaction, it is necessary to develop a strain with or without weakening or conversion of 5′-guanylic acid (GMP) produced while maintaining ATP regeneration.

고속 선별법은 짧은 시간 내에 수천 개 이상의 변이주들 중에서 원하는 형질을 갖는 것을 가려내는 방법인데, 이를 수행하기 위해서는 적합한 선별법이 수행되어야 한다. 현재까지 개발된 일반적인 변이주 선별법은 특정 약재(analogue)를 포함하는 고체 배지상에서 살아남는 변이주를 통해 1차 선별을 한 후, 삼각플라스크를 이용하여 배양하고 일일이 분석을 해야 했다. 이 방법은 삼각플라스크를 이용하여 배양을 하고 분석을 하기 때문에 많은 시간과 노동이 필요했고 수많은 변이주들을 모두 분석하는데 어려움이 많았다. Fast screening is a method of screening for having a desired trait among thousands of mutants in a short time, and an appropriate screening method must be performed to accomplish this. The general mutant screening method developed until now has been subjected to primary screening through mutant strains surviving on a solid medium containing a specific medicine (analogue), followed by incubation using a triangular flask and analysis. This method requires a lot of time and labor because of the culture and analysis using the Erlenmeyer flask, and it was difficult to analyze all the numerous variants.

그러므로 수천 개 이상의 많은 변이체를 배양하고 한꺼번에 분석할 수 있는 방법이 요구되었는데, 그 방법 중 하나가 미니-웰(mini-well)을 이용한 것이다. 작은 부피에서는 다수의 세포를 배양할 수 있고 ELISA 리더 등을 통해 동시 분석이 가능할 수 있기 때문이다. 이를 위해서는 작은 부피에서도 세포가 잘 자랄 수 있도록 적합한 배양 조건이 갖추어져야 하고 동시에 특징을 구별할 수 있는 선별 방법이 필요하다. Therefore, there was a need for a method of culturing and analyzing thousands of many variants at once, one of which is using a mini-well. This is because a small volume can cultivate a large number of cells and can be simultaneously analyzed by an ELISA reader. To this end, suitable culture conditions must be established so that cells can grow well in small volumes, and at the same time, a screening method capable of distinguishing characteristics is required.

이에 따라, 본 발명자들은 고속 선별 방법을 확립하고, 이를 이용함으로써 기존의 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530를 개량하여 5’-구아닐산(GMP)이 저분해 또는 저전환 될 수 있는 형질이 부여된 5’-구아닐산(GMP)의 생산성이 월등히 증가한 변이주를 확인함으로써 본 발명을 완성하였다.Accordingly, the present inventors established a high-speed screening method, and by using the same, by improving the existing Corynebacterium ammonia genes CJXFT0301 KCCM-10530, 5'-guanylic acid (GMP) is a trait that can be degraded or converted low The present invention was completed by identifying mutants with significantly increased productivity of 5'-guanylic acid (GMP).

본 발명의 목적은 코리네박테리움 암모니아게네스 CJFXT0301 KCCM 10530 의 변이주로서, GMP를 분해 또는 전환하는 활성이 현저히 저하된 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P을 제공하는 것이다. 또한, GMP의 분해 또는 전환활성이 저해된 변이주의 고속 선별 방법을 제공하는 것이다.It is an object of the present invention to provide Corynebacterium ammonia genes CJXCV19 KCCM-10692P, which is a mutant of Corynebacterium ammonia genes CJFXT0301 KCCM 10530. In addition, to provide a high-speed screening method of mutant strain inhibited degradation or conversion activity of GMP.

상기 목적을 달성하기 위하여, 본 발명은 미생물 돌연변이 유발하는 제1단계; 상기 1단계의 돌연변이가 유발된 변이체를 미니-웰(mini-well)에서 배양하는 제2단계; 상기 미니-웰에서 배양된 돌연변이의 GMP 분해 및 전환반응을 유도하는 제3단계; 상기 제3단계의 전환반응 조건에서 GMP 감소량을 측정하는 제4단계로 구성됨을 특징으로하는 GMP 저분해 또는 저전환 활성을 갖는 변이주의 고속선별방법 을 제공한다.In order to achieve the above object, the present invention comprises a first step of causing microbial mutation; A second step of culturing the mutant induced by the step 1 mutation in a mini-well; A third step of inducing GMP degradation and conversion of the mutants cultured in the mini-well; It provides a high-speed selection method of mutant strains having a low GMP degradation or low conversion activity characterized in that the fourth step of measuring the amount of GMP reduction in the conversion reaction conditions of the third step.

또한, 본 발명은 코리네박테리움 암모니아게네스 CJFXT0301 KCCM-10530의 변이주로서, 제 1항의 고속선별방법에 의해 선별된 GMP 저분해 또는 저전환 활성을 갖는 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P을 제공한다.In addition, the present invention is a variant of Corynebacterium ammonia genes CJFXT0301 KCCM-10530, Corynebacterium ammonia genes CJXCV19 KCCM-10692P having GMP low degradation or low conversion activity selected by the high-speed screening method of claim 1 To provide.

상기 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P을 이용하여 GMP를 생산하는 방법을 제공한다.It provides a method for producing GMP by using the Corynebacterium ammonia genes CJXCV19 KCCM-10692P.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명은 GMP의 저분해 또는 저전환 활성을 갖는 변이주를 신속하게 선별하기 위하여, 미생물 돌연변이 유발하는 제1단계; 상기 1단계의 돌연변이가 유발된 변이체를 미니-웰(mini-well)에서 배양하는 제2단계; 상기 미니-웰에서 배양된 돌연변이의 GMP 분해 및 전환반응을 유도하는 제3단계; 상기 제3단계의 전환반응 조건에서 GMP 감소량을 측정하는 제4단계로 구성됨을 특징으로 하는 GMP 저분해 또는 저전환 활성을 갖는 변이주의 고속선별방법을 제공한다.The present invention comprises a first step of causing microbial mutations in order to rapidly select mutants having low degradation or low conversion activity of GMP; A second step of culturing the mutant induced by the step 1 mutation in a mini-well; A third step of inducing GMP degradation and conversion of the mutants cultured in the mini-well; It provides a high-speed selection method of mutant strain having a low GMP degradation or low conversion activity characterized in that the fourth step of measuring the amount of GMP reduction in the conversion reaction conditions of the third step.

상기 변이주의 고속선별방법 제1단계에서, 미생물은 모든 미생물에 적용할 수 있으며, 바람직하게는 XMP를 생산할 수 있는 미생물, 더욱 바람직하게는 코리네박테리움 암모니아게네스에 적용할 수 있으며, 돌연변이유발은 자외선 조사, N-메틸 -N`-니트로 -N-니트로소구아니딘(NTG) 등의 변이유발제를 사용하여 통상적인 방법에 따라 변이를 유발할 수 있다. 상기 방법에 의해 변이된 변이체들은 상기 모균주의 활성을 유지하기 모균주를 선별한 배지를 이용하여 모균주 활성을 확보한 변 이체들을 선별할 수 있다.In the first step of the high-speed screening method of the mutant strain, the microorganism may be applied to all microorganisms, preferably to microorganisms capable of producing XMP, more preferably to Corynebacterium ammonia genes, mutagenesis induced The use of a mutagenesis agent such as UV irradiation, N-methyl-N′-nitro-N-nitrosoguanidine (NTG), and the like can cause variation in accordance with conventional methods. The variants mutated by the method may be used to select the variants securing the parent strain activity using a medium for selecting the parent strain to maintain the activity of the parent strain.

상기 변이주의 고속선별법에서 제2단계의 경우, 상기 제1단계에서 선별된 변이주들을 미니-웰에서 배양하며, 미니-웰에서의 배양조건은 배지조건, 배양시간, 접종방법 등 다양한 조합을 통하여 가장 적합한 조건을 확립할 수 있으며, 그 후 세포농도(Abs.562nm) 및 CV(coefficient of variance=분산/평균*100%) 값을 확인함으로써 최상의 조건을 확인할 수 있다.In the second step of the high-speed screening method of the mutant strain, the mutant strains selected in the first stage are incubated in a mini-well, and the culture conditions in the mini-well may be most varied through various combinations such as medium conditions, incubation time, inoculation method Appropriate conditions can be established and the best conditions can then be identified by checking the cell concentration (Abs.562 nm) and CV (coefficient of variance = dispersion / average * 100%) values.

제 3단계의 경우, 상기 미니-웰에서 배양된 변이주에 XMP에서 GMP로의 전환반응을 위한 반응 첨가물 및 GMP를 첨가하여 20-60℃, 바람직하게는 40-50℃에서 교반하면서 전환반응을 수행할 수 있고, 제 4단계의 경우에는 GMP 전환반응조건에서 GMP의 감소량을 측정함으로서 GMP 저분해 또는 저전환 활성을 갖는 변이주를 고속으로 선별하는 방법이다.In the case of the third step, the transformation reaction cultured in the mini-well is added to the reaction additive for the conversion reaction from XMP to GMP and GMP to perform the conversion reaction while stirring at 20-60 ℃, preferably 40-50 ℃ In the case of the fourth step, it is a method of rapidly selecting mutants having low GMP degradation or low conversion activity by measuring the amount of GMP reduction under GMP conversion reaction conditions.

또한, 본 발명은 상기 변이주의 고속선별방법을 이용하여 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530 균주를 모균주로 하여 GMP 저분해 또는 저전환 활성을 갖는 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P를 제공한다.In addition, the present invention using the high-speed selection method of the mutant strain Corynebacterium ammonia genes CJXFT0301 KCCM-10530 strain as a parent strain Corynebacterium ammonia genes CJXCV19 KCCM- having low GMP degradation or low conversion activity Provide 10692P.

상기 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530 균주는 아데닌 요구성, 구아닌 요구성, 라이소자임 감수성, 프롤린유사체 내성, 글루타민유사체 내성 및 트립토판유사체 내성을 보유하면서도 고수율로 XMP를 생산할 수 있는 균주이다. 그러나 XMP에서 GMP로의 낮은 전환율로 인하여 GMP 생산에는 부적합한 균주이다. The Corynebacterium ammonia genes CJXFT0301 KCCM-10530 strain is a strain capable of producing XMP with high yield while retaining adenine requirement, guanine requirement, lysozyme sensitivity, proline analog resistance, glutamine analog resistance and tryptophan analog resistance. However, due to the low conversion rate from XMP to GMP, it is not suitable for GMP production.

따라서, 상기 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530 균주를 모균주로 하여 자외선 조사, N-메틸 -N`-니트로 -N-니트로소구아니딘(NTG) 등의 변이유발제를 사용하여 통상적인 방법에 따라 변이를 유발하여 본 발명의 고속선별법에 의해서 선별된 XMP에서 GMP로의 전환율이 높고, 생성된 GMP의 저분해 또는 저전환 활성을 갖는 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P을 제공한다.Therefore, using the above-mentioned Corynebacterium ammonia genes CJXFT0301 KCCM-10530 strain as a parent strain, UV irradiation, a conventional method using a mutagenesis agent such as N-methyl-N`-nitro -N-nitrosoguanidine (NTG) According to the present invention provides a Corynebacterium ammonia gene CJXCV19 KCCM-10692P having a high conversion rate from XMP to GMP selected by the high-speed screening method of the present invention, and having a low degradation or low conversion activity of the resulting GMP.

본 발명의 변이주는 모균주인 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530의 활성을 모두 유지하여 고수율로 XMP를 생산할 수 있을 뿐만 아니라, GMP 저분해 또는 저전환 활성을 갖고 있고, XMP에서 GMP로의 전환율이 향상되어 고수율, 고농도로 GMP를 생산할 수 있는 균주이다.The mutant of the present invention not only can maintain the activity of the parent strain Corynebacterium ammonia genes CJXFT0301 KCCM-10530 to produce XMP in high yield, but also has GMP low degradation or low conversion activity, and GMP in GMP It is a strain capable of producing GMP with high yield and high concentration due to improved conversion rate.

따라서, 본 발명은 변이주인 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P을 이용한 GMP 생산방법을 제공한다.Accordingly, the present invention provides a GMP production method using a variant strain Corynebacterium ammonia genes CJXCV19 KCCM-10692P.

이하, 본 발명을 하기의 실시예 및 실험예에 의하여 더욱 상세히 설명한다. 다만, 하기의 실시예 및 실험예는 본 발명의 예시일 뿐, 본 발명이 이에 의하여 한정되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to the following Examples and Experimental Examples. However, the following Examples and Experimental Examples are only examples of the present invention, and the present invention is not limited thereto.

참조예Reference Example 1.  One. 배지조성Badge composition

1-1. 프롤린 유사체 및 글루타민 유사체가 첨가된 1-1. Proline analogues and glutamine analogues added 최소배지Minimum badge

포도당 20g/L, 인산제1칼륨 1g/L, 인산제2칼륨 1g/L, 우레아 2g/L, 황산암모늄 3g/L, 황산마그네슘 1g/L, 염화칼슘 100mg/L, 황산철 20mg/L, 황산망간 10mg/L, 황산아연 10mg/L, 비오틴 30ug/L, 티아민산염 0.1mg/L, 황산구리 0.8mg/L, 아데닌 20mg/L, 구아닌 20mg/L, 프롤린유사체 100mg/L, 글루타민유사체 100mg/L으로 조성되며, pH 7.2로 조정하였다.Glucose 20g / L, Potassium phosphate 1g / L, Dipotassium phosphate 1g / L, Urea 2g / L, Ammonium sulfate 3g / L, Magnesium sulfate 1g / L, Calcium chloride 100mg / L, Iron sulfate 20mg / L, Sulfuric acid Manganese 10mg / L, Zinc sulfate 10mg / L, Biotin 30ug / L, Thiarate 0.1mg / L, Copper sulfate 0.8mg / L, Adenine 20mg / L, Guanine 20mg / L, Proline analog 100mg / L, Glutamine analog 100mg / L Formulated and adjusted to pH 7.2.

1-2. 소규모(Mini-scale) 배양 배지1-2. Mini-scale culture medium

포도당 10g/L, 펩톤 10g/L, 효모엑기스 5g/L, 염화나트륨 2.5g/L, 우레아 3g/L, 아데닌 200mg/L, 구아닌 200mg/L로 구성되며, pH 7.2로 조정하였다.10 g / L glucose, 10 g / L peptone, 5 g / L yeast extract, 2.5 g / L sodium chloride, 3 g / L urea, 200 mg / L adenine, 200 mg / L guanine, adjusted to pH 7.2.

1-3. 5’-1-3. 5’- 크산틸산(XMP)에서In Xanthanic Acid (XMP) 5’- 5’- 구아닐산(GMP)로의To guanylic acid (GMP) 전환반응 첨가물 Conversion reaction additive

피틴산(phytic acid) 1.8g/L, MgSO4 4.8g/L, 니민(Nymeen) 3㎖/L, 아데닌 100mg/L, Na2HPO4 7.7g/L, 글루코스 46g/L로 조성되었다.Phytic acid (1.8 g / L), MgSO 4 4.8 g / L, Nimine (3 ml / L), adenine 100 mg / L, Na 2 HPO 4 7.7 g / L, glucose 46 g / L.

실시예Example 1. 균주의 준비 1. Preparation of Strains

변이주 제작을 위한 모균주로서 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530을 준비하였다.Corynebacterium ammonia genes CJXFT0301 KCCM-10530 was prepared as a parent strain for the production of mutant strains.

실험예Experimental Example 1. 소규모 배양조건 확립 1. Establishment of small scale culture conditions

소규모(Mini-scale)에서 코리네박테리움 암모니아게네스 야생주 및 본 발명의 모균주 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530의 정상 배양을 위한 조건을 확립하기 위해 배지조건, 배양시간, 접종 방법 등의 다양한 조합을 통해 가장 적합한 조건을 확립하였다.Medium conditions, incubation time, inoculation to establish conditions for normal culture of Corynebacterium ammonia genes wild strain and parent strain Corynebacterium ammonia genes CJXFT0301 KCCM-10530 at a mini-scale Various combinations of methods and the like have established the most suitable conditions.

야생주는 배양 2일 후 50배 희석한 평균 세포 농도(Abs.562nm) 0.29를 나타내었고, 표준 편차 0.025를 나타내었다. 고속선별법으로서의 타당성을 측정하는 지표인 CV(coefficient of variance=분산/평균*100%)값은 8.9%를 나타내 적합한 조건임을 확인하였다(도 1 참조). The wild line exhibited an average cell concentration (Abs.562 nm) of 0.29 diluted 50-fold after 2 days of culture and a standard deviation of 0.025. CV (coefficient of variance = variance / average * 100%) value, which is an index for measuring the validity as a high-speed screening method, was found to be 8.9% and was a suitable condition (see FIG. 1).

또한 모균주 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530의 경우 하루를 배양한 후 계대하여 추가로 2일 배양을 하였을 경우 30배 희석한 평균 세포 성장 농도(Abs.562nm) 0.26, 표준편차 0.020, 그리고 CV값은 7.7%를 나타냄을 확인할 수 있었다(도 2 참조). In addition, in the case of the parent strain Corynebacterium ammonia genes CJXFT0301 KCCM-10530, the average cell growth concentration (Abs.562nm) 0.26, standard deviation 0.020, And CV value was confirmed to represent 7.7% (see Fig. 2).

따라서, 야생주와 변이주에 모두에 적합한 소규모에서의 배양 조건을 확립할 수 있었다. Thus, culture conditions at small scale suitable for both wild and mutant strains could be established.

실험예Experimental Example 2. 5’-구아닐산의 분해 또는 전환 반응의 정확한 실험과 측정을 위한 고속 선별법의 조건확립 2. Establishment of conditions for high-speed screening for accurate experiments and measurement of 5′-guanylic acid degradation or conversion reactions

소규모에서의 5’-구아닐산의 분해 또는 전환 반응의 정확한 실험과 측정을 위한 고속 선별법의 조건을 찾기 위해 특성이 다른 균주들을 대상으로 수행하였다. 코리네박테리움 암모니아게네스 야생주와 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530 그리고 5’-구아닐산의 분해가 없는 대조군을 선택하였다.Strains with different characteristics were performed to find the conditions of high-speed screening for accurate experiments and measurement of degradation or conversion reactions of 5′-guanylic acid at small scale. Corynebacterium ammonia genes wild and Corynebacterium ammonia genes CJXFT0301 KCCM-10530 and 5'-guanylic acid free control was selected.

총 3종의 균주를 소규모에서의 전환반응 조건인 상기 참조예 1-3의 반응 첨가물 및 5’-구아닐산(GMP)첨가, 42℃에서 교반하였다. 시간을 변수로 3종간의 차 이가 가장 많이 나는 시간을 구하였다. 반응 후에는 세포를 침전시키고 상등액만을 취하여 50배 희석한 후 멀티 웰 리더(multi-well reader, Abs. 290nm)를 이용하여 5’-구아닐산(GMP)의 변화량을 측정하였다. A total of three strains were stirred at 42 ° C. with the reaction additive of Reference Example 1-3 and 5′-guanylic acid (GMP), which are conversion conditions at small scale. We calculated the time with the largest difference between the three types using time as a variable. After the reaction, the cells were precipitated, the supernatant was taken 50 times, diluted, and the change amount of 5′-guanylic acid (GMP) was measured using a multi-well reader (Abs. 290 nm).

상기 실험 수행의 결과, 야생주와 변이주간의 차이가 명확한 조건을 확립할 수 있었다(도 3 참조). 야생주에 비해 모주인 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530은 이미 5’-구아닐산(GMP) 분해력이 감소한 것으로 그 차이가 약 3배 정도를 보였으나 분해가 없는 대조군에 비해 아직 분해 활성이 많이 남아있었다. 더 오랜 반응 시간과 희석배수를 늘리면 그 차이를 더 크게 나타낼 수 있음을 확인할 수 있었다. As a result of the experiment, it was possible to establish a clear condition between the wild and mutant strains (see FIG. 3). Compared with wild wines, the parent strain, Corynebacterium ammonia genes CJXFT0301 KCCM-10530, has already reduced the 5'-guanylic acid (GMP) degradation ability, but the difference was about 3 times, but the degradation activity was still higher than that of the control group without degradation. Many remained. Increasing the reaction time and dilution factor was found to show a larger difference.

실험예Experimental Example 3. 변이주  3. Variation 코리네박테리움Corynebacterium 암모니아게네스Ammonia Genes CJXCV19CJXCV19 제작 making

5’-구아닐산(GMP) 저분해 또는 저전환 변이체를 획득하기 위해 상기 실시예 1에서 준비한 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530를 모균주로 하고, 변이 유발제인 N-메틸 -N`-니트로 -N-니트로소구아니딘(NTG)을 사용하여 통상적인 방법에 따라 변이체 라이브러리를 제작하였다.Corynebacterium ammonia genes CJXFT0301 KCCM-10530 prepared in Example 1 to obtain a 5'-guanylic acid (GMP) low degradation or low conversion variants as a parent strain, N-methyl -N`- which is a mutagenesis agent Variant libraries were prepared according to conventional methods using nitro-N-nitrosoguanidine (NTG).

상기 변이체 라이브러리를 모균주 선별 배지인 상기 참조예 1-1의 프롤린 유사체 및 글루타민 유사체가 첨가된 최소배지에 도말 하여 생성된 콜로니들을 확보하였다. The mutant library was plated in a minimal medium to which the proline and glutamine analogues of Reference Example 1-1, the parental strain selection medium, were added to secure colonies.

상기 확보된 콜리니들을 미니 웰(mini-well, 96well Deep Plate-Dome, Cat 90061, 주식회사 바이오니아)에 옮기기 위해 Q-bot(Cat X8000)을 이용하여 피킹하 여 옮긴 후, 상기 참조예 1-2의 배양배지에서 48시간 동안 배양하였다. 배양은 변이주들의 안전한 배양을 위해 증발, 온도, 산소공급을 조절하는 배양기인 HT-MegaGrowTM 교반 인큐베이터(HT-MegaGrowTM Shaking Incubator, Cat. A-4080, 주식회사 바이오니아)를 사용하여 배양하였다.The obtained colonies were picked and transferred using Q-bot (Cat X8000) to transfer them to mini-wells (mini-well, 96well Deep Plate-Dome, Cat 90061, Bioneer, Inc.). Incubated for 48 hours in the culture medium. The culture is incubated with the evaporation, the temperature, the culture medium HT-MegaGrow TM stirring incubator (HT-MegaGrow TM Shaking Incubator, Cat. A-4080, Bioneer Co., Ltd.) to adjust the oxygen supply to the culture of the mutant safe.

그 후 상기 참조예 1-3의 첨가물 및 GMP 5g/L를 첨가하여 42℃ 에서 4시간동안 교반하여 전환반응을 수행하였다. 상기 전환반응 전, 후의 GMP의 농도를 측정하기 위해 멀티-웰 리더(Cat.MDK050315-1, Molecular Devices 사)를 이용하여 Abs.290nm에서의 값을 측정하여 GMP 반응후 농도가 가장 높은 것을 선별하였다.Thereafter, the additive of Reference Example 1-3 and 5 g / L of GMP were added thereto, followed by stirring at 42 ° C. for 4 hours to perform a conversion reaction. In order to measure the concentration of GMP before and after the conversion reaction, the highest concentration after GMP reaction was selected by measuring the value at Abs.290 nm using a multi-well reader (Cat.MDK050315-1, Molecular Devices). .

모균주가 Abs.290nm에서 0.6의 값을 보일 때 약 0.8이상의 값을 나타내는 변이체들을 선별하였다. 상기 선별된 변이체들을 하기와 같은 방법으로 삼각플라스크 발효를 수행하였다.When the parent strain showed a value of 0.6 at Abs.290 nm, the variants showing values of about 0.8 or more were selected. The selected variants were subjected to Erlenmeyer flask fermentation in the following manner.

종배지(포도당 30g/L, 펩톤 15g/L, 효모엑기스 15g/L, 염화나트륨 2.5g/L, 우레아 3g/L, 아데닌 150mg/L, 구아닌 150mg/L, pH 7.2) 5ml을 지름 18mm 시험관에 분주하고 상법에 따라 가압 살균한 후 사용 균주를 접종하고 180rpm으로 30℃에서 18시간 진탕 배양하여 종배양액으로 사용하였다. 발효배지 중 본배지(포도당 60g/L, 황산마그네슘 10g/L, 황산철 20mg/L, 황산아연 10mg/L, 황산망간 10mg/L, 아데닌 30mg/L, 구아닌 30mg/L, 비오틴 100ug/L, 황산구리 1mg/L, 티아민염산염 5mg/L, 염화칼슘 10mg/L, pH 7.2)와 별살배지(인산제1칼륨 10g/L, 인산제2칼륨 10g/L, 우레아 7g/L, 황산암모늄 5g/L)를 각각 상법에 따라 가압 살균하여 미리 가 압 살균한 500mL 용량의 진탕용 삼각 플라스크에 29mL과 10mL 씩 분주하고 종배양액 1mL을 식균한 다음 90시간 배양하였다. 회전수는 200rpm, 온도 30℃로 조절하였다. 5 ml of seed medium (30 g / L glucose, 15 g / L peptone, 15 g / L yeast extract, 2.5 g / L sodium chloride, 3 g / L urea, 150 mg / L adenine, guanine 150 mg / L, pH 7.2) is dispensed into an 18 mm diameter test tube After autoclaving according to the conventional method, the inoculated strain was used and the culture was shaken at 180 ° C. for 18 hours at 30 ° C. to be used as a seed culture solution. Main medium in fermentation medium (glucose 60g / L, magnesium sulfate 10g / L, iron sulfate 20mg / L, zinc sulfate 10mg / L, manganese sulfate 10mg / L, adenine 30mg / L, guanine 30mg / L, biotin 100ug / L, Copper sulfate 1mg / L, thiamine hydrochloride 5mg / L, calcium chloride 10mg / L, pH 7.2) and starch medium (10 g / L potassium phosphate, 10 g / L potassium phosphate, urea 7 g / L, ammonium sulfate 5 g / L) After autoclaving according to the conventional method, 29mL and 10mL were respectively dispensed into a 500mL shake-type Erlenmeyer flask which was autoclaved in advance, and 1mL of the seed culture solution was inoculated and then incubated for 90 hours. The rotation speed was adjusted to 200 rpm and temperature 30 degreeC.

상기 삼각플라스크 배양후 5’-크산틸산의 농도가 유지되거나 높은 것을 최종 선별하여, 코리네박테리움 암모니아게네스 CJXCV19라 명명하고, 이를 2005년 11월 9일자에 한국미생물보존센터에 기탁하였고, 기탁번호는 KCCM-10692P이다. After the Erlenmeyer flask culture, the concentration of 5'-xanthyl acid was maintained or high was finally selected and named Corynebacterium ammonia genes CJXCV19, which was deposited on November 9, 2005 at the Korea Microorganism Conservation Center and deposited. The number is KCCM-10692P.

상기 삼각플라스트 배양 완료 후 5’-크산틸산의 배지내 축적량은 모균주인 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530의 경우가 30.1 g/L 이며, 본 발명의 변이주인 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P의 경우는 32.2g/L임을 확인할 수 있었다. (5’-크산틸산의 축적 농도는 5’-크산틸산 나트륨·7H2O로 표시하였다.)After completion of the Erlenmeyer platter culture, the accumulation amount of 5'-xanthyl acid in the medium was 30.1 g / L in the case of the parent strain Corynebacterium ammonia genes CJXFT0301 KCCM-10530, and the variant strain Corynebacterium ammonia of the present invention. The case of Gennes CJXCV19 KCCM-10692P was confirmed to be 32.2g / L. (The cumulative concentration of 5'-xanthyl acid was expressed as 5'-sodium xanthate.7H2O.)

실험예Experimental Example 4. 5’- 4. 5’- 구아닐산(GMP)로의To guanylic acid (GMP) 전환 반응 Conversion reaction

5’-구아닐산(GMP)로의 전환 반응은 상기 실험 예 3의 5’-크산틸산(XMP) 삼각플라스크 발효액 40mL에 상기 참조예 1-3의 반응 첨가물 2.8mL과 XMP 아미나아제를 생산하는 대장균 발효액 4.2mL을 첨가하여 42℃, 170rpm에서 24시간동안 전환반응을 수행하였다.The conversion reaction to 5'-guanylic acid (GMP) was carried out in 40 mL of the 5'-xanthyl acid (XMP) Erlenmeyer flask fermentation broth of Experimental Example 3, E. coli fermentation broth producing 2.8 mL of the reaction additive of Reference Example 1-3 and XMP aminase 4.2. The addition of mL was carried out for 24 hours at 42 ℃, 170 rpm conversion.

상기 실험 수행의 결과, 모균주인 코리네박테리움 암모니아게네스 CJXFT0301 KCCM-10530의 경우는 배양액내의 5’-구아닐산(GMP)의 양이 22.5g/L로 75%의 전환율을 보였고, 본 발명의 변이주인 코리네박테리움 암모니앙게네스 CJXCV19 KCCM- 10692P는 26.1g/L로 81%의 전환율을 보임을 확인할 수 있었다.As a result of the experiment, the parent strain Corynebacterium ammonia genes CJXFT0301 KCCM-10530 showed a conversion rate of 75% to 22.5 g / L of 5'-guanylic acid (GMP) in the culture medium, The mutant strain Corynebacterium ammonia angenes CJXCV19 KCCM-10692P was found to have a conversion rate of 81% at 26.1g / L.

상술한 바와 같이, 본 발명은 미생물에 돌연변이를 유발한 변이주들 중에서 GMP 저분해 또는 저전환 활성을 갖는 변이주의 고속선별방법을 제공하며, 상기 방법에 의해 선별된 변이주 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P 및 이를 이용한 GMP 생산방법을 제공한다.As described above, the present invention provides a high-speed screening method of mutant strains having GMP low degradation or low conversion activity among the mutant strains causing microorganisms, and the strain strain Corynebacterium ammonia genes CJXCV19 selected by the method It provides KCCM-10692P and GMP production method using the same.

본 발명에 의한 고속선별방법은 수많은 변이체를 배양하여 한꺼번에 분석함으로서 선별하고자 하는 특성을 지닌 변이주를 손쉬우면서도 간편하게 단시간내에 선별할 수 있는 방법이다. 또한, 상기 방법에 의해 선별된 코리네박테리움 암모니아게네스 CJXCV19 KCCM-10692P는 모균주인 코리네박테리움 암모니아게네스 CJFXT0301 KCCM-10530의 특징을 모두 보유하고 있어 XMP를 고수율로 생산할 수 있으면서도, GMP 저분해 또는 저전환 활성을 가지고 있으며, XMP에서 GMP로의 전환율도 향상되어 고수율로 GMP로 생산할 수 있는 균주이다. 따라서, 상기 균주를 이용하여 고수율, 고농도로 GMP를 생산할 수 있다.The high-speed screening method according to the present invention is a method that can easily and easily select a mutant strain having a characteristic to be selected by culturing a number of variants at a time and easy to analyze. In addition, Corynebacterium ammonia genes CJXCV19 KCCM-10692P selected by the above method possesses all of the characteristics of the parent strain Corynebacterium ammonia genes CJFXT0301 KCCM-10530, while producing high yield of XMP, GMP has a low degradation or low conversion activity, and the conversion rate from XMP to GMP is also improved and can be produced in high yield GMP. Therefore, the strain can be used to produce GMP with high yield and high concentration.

Claims (3)

코리네박테리움 암모니아게네스(Corynebacterium ammoniagenes) CJFXT0301 KCCM-10530의 돌연변이체를 미니-웰(mini-well)에서 배양하는 단계; 상기 미니-웰에서 배양된 돌연변이체의 5'-구아닐산(Guanine monophosphate: GMP)으로의 전환반응을 유도하는 단계; 상기 전환반응 단계에서 5'-구아닐산의 농도를 측정하여 290nm에서 모균주의 흡광도가 0.6일 때 0.8 이상의 값을 나타내는 변이주를 선별하는 단계를 포함함을 특징으로 하는 코리네박테리움 암모니아게네스(Corynebacterium ammoniagenes) CJFXT0301 KCCM-10530 변이주의 고속선별방법.Culturing the mutant of Corynebacterium ammoniagenes CJFXT0301 KCCM-10530 in a mini-well; Inducing a conversion of mutants cultured in the mini-well to 5'-guanylic acid (Guanine monophosphate (GMP)); Corynebacterium ammonia gene ( Coynebacterium ) characterized in that the step of measuring the concentration of 5'- guanylic acid in the conversion reaction step of selecting a mutant strain exhibiting a value of 0.8 or more when the absorbance of the parent strain at 290nm is 0.6 ammoniagenes ) CJFXT0301 KCCM-10530 High-speed screening method for mutant strains. 코리네박테리움 암모니아게네스(Corynebacterium ammoniagenes) CJFXT0301 KCCM-10530의 변이주로서, 5'-크산틸산을 생산하고, 5'-크산틸산에서 5'-구아닐산으로의 전환율이 모균주에 비해 향상된 코리네박테리움 암모니아게네스(Corynebacterium ammoniagenes) CJXCV19 KCCM-10692P. Corynebacterium ammoniagenes CJFXT0301 KCCM-10530, a variant of Corynebacterium ammoniagenes that produces 5'-xanthyl acid and converts 5'-xanthyl acid to 5'-guanylic acid compared to the parent strain Corynebacterium ammoniagenes CJXCV19 KCCM-10692P. 코리네박테리움 암모니아게네스(Corynebacterium ammoniagenes) CJXCV19 KCCM-10692P을 이용하여 5'-구아닐산을 생산하는 방법.A method for producing 5'-guanylic acid using Corynebacterium ammoniagenes CJXCV19 KCCM-10692P.
KR1020050113712A 2005-11-25 2005-11-25 Corynebacterium ammoniagenes cjxcv19 kccm-10692p having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant KR100686561B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020050113712A KR100686561B1 (en) 2005-11-25 2005-11-25 Corynebacterium ammoniagenes cjxcv19 kccm-10692p having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050113712A KR100686561B1 (en) 2005-11-25 2005-11-25 Corynebacterium ammoniagenes cjxcv19 kccm-10692p having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant

Publications (1)

Publication Number Publication Date
KR100686561B1 true KR100686561B1 (en) 2007-02-26

Family

ID=38104529

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050113712A KR100686561B1 (en) 2005-11-25 2005-11-25 Corynebacterium ammoniagenes cjxcv19 kccm-10692p having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant

Country Status (1)

Country Link
KR (1) KR100686561B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009091228A2 (en) * 2008-01-18 2009-07-23 Cj Cheiljedang Corporation Guanosine monophosphate kinase variant having reduced gmp conversion activity

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040051731A (en) * 2002-12-11 2004-06-19 씨제이 주식회사 Microorganism producing 5’-Xanthylic acid
US6821768B2 (en) 2001-12-28 2004-11-23 Cj Corporation Corynebacterium ammoniagenes KCCM 10340 for producing 5'-xanthylic acid
KR20050062027A (en) * 2003-12-19 2005-06-23 씨제이 주식회사 Recombinant microorganisms of escherichia having an inactivated usha gene and processes for accumulating 5'-guanilic acid synthase in a medium using the same
KR20060084994A (en) * 2005-01-21 2006-07-26 씨제이 주식회사 Escherichia coli strain capable of converting xmp to gmp and having inactivated genes for gmp degradation and method for using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821768B2 (en) 2001-12-28 2004-11-23 Cj Corporation Corynebacterium ammoniagenes KCCM 10340 for producing 5'-xanthylic acid
KR20040051731A (en) * 2002-12-11 2004-06-19 씨제이 주식회사 Microorganism producing 5’-Xanthylic acid
KR20050062027A (en) * 2003-12-19 2005-06-23 씨제이 주식회사 Recombinant microorganisms of escherichia having an inactivated usha gene and processes for accumulating 5'-guanilic acid synthase in a medium using the same
KR20060084994A (en) * 2005-01-21 2006-07-26 씨제이 주식회사 Escherichia coli strain capable of converting xmp to gmp and having inactivated genes for gmp degradation and method for using the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009091228A2 (en) * 2008-01-18 2009-07-23 Cj Cheiljedang Corporation Guanosine monophosphate kinase variant having reduced gmp conversion activity
WO2009091228A3 (en) * 2008-01-18 2009-10-29 씨제이제일제당(주) Guanosine monophosphate kinase variant having reduced gmp conversion activity
KR101000669B1 (en) 2008-01-18 2010-12-10 씨제이제일제당 (주) A mutated guanosine monophosphate kinase having weak gmp conversion activity

Similar Documents

Publication Publication Date Title
Streicher et al. Transduction of the nitrogen-fixation genes in Klebsiella pneumoniae
EP2115120B1 (en) Microorganism producing inosine and method of producing inosine using the same
KR20130056587A (en) Microorganisms for producing 5'-xanthylic acid and methods for preparing 5'-xanthylic acid
KR100655902B1 (en) Corynebacterium ammoniagenes cjxcv24 kccm-10693p having high activity of convertion of xmp to gmp
KR20070056491A (en) Microorganisms having a gene purf and production method of xanthosine 5'-monophosphate using the same
AU2002323752B2 (en) Microorganism overproducing 5'-xanthylic acid
KR100686561B1 (en) Corynebacterium ammoniagenes cjxcv19 kccm-10692p having low activity of degradation of guanine 5'- monophosphate and high-throughput screening method for mutant
KR101653245B1 (en) Fermentation process for preparing thymidine by the recombinant E. coli
CN102586383B (en) Process for preparing cytidine diphosphate choline
CN100552037C (en) The biosynthetic means of 5 ' flavour nucleotide
RU2312137C2 (en) Strain corynebacterium ammoniagenes as producer of 5'-xanthylic acid and method for preparing 5'-xanthylic acid
KR100401364B1 (en) Mutant strain of Corynebacterium ammoniagenes producing thymidine and its fermentation method for producing thymidine
KR100547586B1 (en) Recombinant Escherichia spp. microorganisms in which the uShA gene is inactivated and 5'-guanylic acid synthase using the same
WO2006059877A1 (en) Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same
KR100588577B1 (en) Microorganism producing 5?-inosinic acid and production method of 5?-inosinic acid using the same
US3725201A (en) Manufacture of uridine-5-diphosphoglucuronic acid
KR100442574B1 (en) Novel yeast mutant containing increased RNA content and method of mass-producing of the same
KR100671081B1 (en) Microorganism producing inosine and process of preparing 5'-inosinic acid using same
US6764841B2 (en) Production process of glucose-1-phosphate
KR100330705B1 (en) Inosine-producing microorganism and method for preparing inosine using the same
KR100330706B1 (en) 5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same
KR100429926B1 (en) Microorganism overproducing 5’-xanthylic acid
KR970002249B1 (en) MICROORGANISM PRODUCING 5óÑ-XANTHYL ACID
KR100424847B1 (en) 5'-inosinic acid producing microorganism and process for production thereof
KR970000587B1 (en) Microorganism producing gmp

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121218

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20131128

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20141226

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20151228

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20171129

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20181126

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20191125

Year of fee payment: 14